Beyond Rescheduling: What Investors Should Really Watch in U.S. Cannabis and Why Europe Should Care!
There is a growing sense that the United States is finally close to something on cannabis. Not certainty. Not clarity. But momentum. Rescheduling cannabis from Schedule I to Schedule III, if it happens, would be meaningful. It would signal that the federal government is prepared to acknowledge medical utility, reduce some of the most punitive […]
